Chitosan Increases α6 Integrinhigh/CD71highHuman Keratinocyte Transit-Amplifying Cell Population

Dong-Wook Shin, Joong-Hyun Shim, Yoon-Kyung Kim, Eui-Dong Son, Seung-Ha Yang, Hye-Jin Jeong, Seok-Yong Lee, Han-Kon Kim, Soo-Nam Park, Min-Soo Noh
2010 Biomolecules & Therapeutics  
Glycosaminoglycans (GAGs) and chitosan have been used as matrix materials to support the dermal part of skin equivalent which is used for both pharmacological and toxicological evaluations of drugs potentially used for dermatological diseases. However, their biological roles of GAGs and chitosan in the skin equivalent are still unknown. In the present study, we evaluated whether GAGs and chitosan directly affect keratinocyte stem cells (KSCs) and their transit-amplifying cells (TA cells). Among
more » ... s (TA cells). Among supporting matrix materials, chitosan significantly increased the number of α6 integrin high /CD71 high human keratinocyte TA cells by 48.5%. In quantitative real-time RT-PCR analysis, chitosan significantly increased CD71 and CD200 gene transcription whereas not α6 integrin. In addition, the level of the gene transcription of both keratin 1 (K1) and K10 in the chitosan-treated human keratinocytes was significantly lower than those of control, suggesting that chitosan inhibit keratinocyte differentiation. We also found that N-acetyl-D-glucosamine (NAG) and β-(1-4)-linked D-glucosamine (D-glc), two components of chitosan, have no effect on the expression of CD71, K1, and K10, suggesting that each monomer component of chitosan is not enough to regulate the number of epidermal keratinocyte lineage. Conclusively, chitosan increases keratinocyte TA cell population which may contribute to the cellular mass expansion of the epidermal part of a skin equivalent system.
doi:10.4062/biomolther.2010.18.3.280 fatcat:yfty33qp65c2vhpnqjkcy3s26y